The PE Ratio as of December 2025 (TTM) for Australian Clinical Labs Limited (ACL.AX) is 16.47

According to Australian Clinical Labs Limited’s latest financial reports and current stock price. The company's current PE Ratio is 16.47. This represents a change of 16.28% compared to the average of 14.16 of the last 4 quarters.

Australian Clinical Labs Limited (ACL.AX) Historical PE Ratio (quarterly & annually)

How has ACL.AX PE Ratio performed in the past?

The mean historical PE Ratio of Australian Clinical Labs Limited over the last ten years is -9.38. The current 16.47 PE Ratio has changed -17662.54% with respect to the historical average. Over the past ten years (40 quarters), ACL.AX's PE Ratio was at its highest in in the June 2021 quarter at 51.99. The PE Ratio was at its lowest in in the December 2019 quarter at -54.05.

Australian Clinical Labs Limited (ACL.AX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Australian Clinical Labs Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Australian Clinical Labs Limited (ACL.AX) Average PE Ratio

How has ACL.AX PE Ratio performed in the past?

The current PE Ratio of Australian Clinical Labs Limited (ACL.AX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Australian Clinical Labs Limited (ACL.AX) PE Ratio vs. Peers

How is ACL.AX’s PE Ratio compared to its peers?

Australian Clinical Labs Limited’s PE Ratio is less than Oceania Healthcare Limited (21.55), greater than Healius Limited (-4.68), less than Paragon Care Limited (20.67), less than Clinuvel Pharmaceuticals Limited (17.65), greater than EBR Systems, Inc. (-6.04), less than Cogstate Limited (23.29), greater than Monash IVF Group Limited (12.73), greater than Race Oncology Limited (-91.34), greater than Immutep Limited (-8.78), greater than Mayne Pharma Group Limited (-2.64),

Build a custom stock screener for Australian Clinical Labs Limited (ACL.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Australian Clinical Labs Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Australian Clinical Labs Limited (ACL.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Australian Clinical Labs Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.